1. Home
  2. CDIO vs EVGN Comparison

CDIO vs EVGN Comparison

Compare CDIO & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

N/A

Current Price

$1.65

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Logo Evogene Ltd

EVGN

Evogene Ltd

N/A

Current Price

$0.33

Market Cap

5.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CDIO
EVGN
Founded
2017
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
5.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
CDIO
EVGN
Price
$1.65
$0.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.9K
★ 173.1K
Earning Date
12-01-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $14,825.00
N/A
Revenue This Year
$168,534.06
N/A
Revenue Next Year
N/A
$81.06
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.97
$0.25
52 Week High
$7.91
$1.26

Technical Indicators

Market Signals
Indicator
CDIO
EVGN
Relative Strength Index (RSI) 41.69 41.63
Support Level $1.53 $0.25
Resistance Level $2.20 $0.41
Average True Range (ATR) 0.13 0.05
MACD -0.00 0.00
Stochastic Oscillator 12.87 31.46

Price Performance

Historical Comparison
CDIO
EVGN

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: